Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers
Fabiana Ciciriello, Marcel J. C. Bijvelds, Federico Alghisi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 632-632
Open Access | Times Cited: 19

Showing 19 citing articles:

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription
Elise Dréano, Pierre‐Régis Burgel, Aurélie Hatton, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 4, pp. 2300110-2300110
Closed Access | Times Cited: 51
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
Burkhard Tümmler
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers
Jessica Conti, Dora Angyal, Karina Kleinfelder, et al.
Journal of Cystic Fibrosis (2025)
Open Access
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
Iris A. L. Silva, Onofrio Laselva, Miquéias Lopes‐Pacheco
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1321-1321
Open Access | Times Cited: 21
Additive Potentiation of R334W-CFTR Function by Novel Small Molecules
Mafalda Bacalhau, Filipa C. Ferreira, Iris A. L. Silva, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 1, pp. 102-102
Open Access | Times Cited: 9
Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
Liron Birimberg‐Schwartz, Wan Ip, Claire Bartlett, et al.
Life Science Alliance (2023) Vol. 6, Iss. 6, pp. e202201857-e202201857
Open Access | Times Cited: 9
Elexacaftor/tezacaftor/ivacaftor efficacy in intestinal organoids with rare CFTR variants in comparison to CFTR-F508del and CFTR-wild type controls
Suzanne Kroes, Marlou C. Bierlaagh, Juliet Lefferts, et al.
Journal of Cystic Fibrosis (2024)
Closed Access | Times Cited: 3
Patient-derived cell models for personalized medicine approaches in cystic fibrosis
Anabela S. Ramalho, Felice Amato, Martina Gentzsch
Journal of Cystic Fibrosis (2022) Vol. 22, pp. S32-S38
Open Access | Times Cited: 15
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast
Roberta Valeria Latorre, Martina Calicchia, Martina Bigliardi, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 3, pp. 455-461
Open Access | Times Cited: 2
Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA/R334W genotype
Georgia Mitropoulou, Nathalie Brandenberg, Sylke Hoehnel, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2201341-2201341
Closed Access | Times Cited: 12
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis
Jessica Conti, Claudio Sorio, Paola Melotti
Children (2022) Vol. 10, Iss. 1, pp. 4-4
Open Access | Times Cited: 9
S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy in vivo and in vitro in matched pediatric patient-derived cell models
Katelin M. Allan, Miro A. Astore, Laura K. Fawcett, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 4
Lower Expression of CFTR Is Associated with Higher Mortality in a Meta-Analysis of Individuals with Colorectal Cancer
Patricia M. Scott, Shuo Wang, Guillaume C. Onyeaghala, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 989-989
Open Access | Times Cited: 2
Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium
Mirosław Zając, Agathe Lepissier, Elise Dréano, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids
Karina Kleinfelder, Paola Melotti, Anca Manuela Hristodor, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access
Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient
Katelin M. Allan, Miro A. Astore, Egi Kardia, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
Putting Bicarbonate on the spot. Implication for theratyping in Cystic Fibrosis
Mirosław Zając, Agathe Lepissier, Elise Dréano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening
Zoran Laurentiu Popa, Mădălin-Marius Margan, Izabella Petre, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8698-8698
Open Access
Page 1

Scroll to top